Here are four notes:
1. For years, FDA officials claimed physicians should not be mandated to undergo training for opioid prescribing.
2. The Associated Press found less than half of physicians the FDA targeted participated in the voluntary program, according to The Hill.
3. The American Medical Association has strongly opposed any standardized training requirements, saying physicians should be able to choose to participate.
4. The FDA’s decision is likely in response to the growing number of opioid-related deaths.
More articles on quality & infection control:
AHRQ names Dr. Andrew Bindman director — 5 highlights
Sen. John Cornyn pushes back against $1.9B Zika emergency fund — 3 notes
MPIRICA Health adds 1M+ outpatient quality scores — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.